Clinical Trials Browser

Phase 3 × Terminated × Olanzapine × Clear all

NCT04503668 2025-06-18

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Phase 3 Terminated

62 enrolled 16 charts

Gynecologic Cancer

NCT00124930 2012-01-19

Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

Phase 3 Terminated

Nausea, Neoplasms